Literature DB >> 6807232

Staphylococcal bacteremia and endocarditis: state of the art.

A S Bayer.   

Abstract

The major clinical difficulties in bacteremic Staphylococcus aureus infections involve the following: (1) differentiation of infective endocarditis (IE) from non-IE staphylococcemias and (2) questions concerning optimum chemotherapy of deep-seated staphylococcemic infections. In this article, an algorithmic approach to the differentiation of S aureus IE from non-IE staphylococcemias will be developed, particularly in regard to specific clinical, echocardiographic, radioisotopic, and serological "markers" for recognizing patients as at "high risk" for underlying S aureus IE. Also, data will be presented relating to the controversies of monotherapy v combination chemotherapy in S aureus IE as well as in bacteremic S aureus infections caused by antibiotic-tolerant S aureus strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807232

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

1.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.

Authors:  María Pilar Trotonda; Yan Q Xiong; Guido Memmi; Arnold S Bayer; Ambrose L Cheung
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

3.  Repeated echocardiography: essential in the management of Staphylococcus aureus endocarditis.

Authors:  J J O'Sullivan; T Aherne; J Erwin
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

4.  Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits.

Authors:  A L Cheung; M R Yeaman; P M Sullam; M D Witt; A S Bayer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 5.  Recognition, management and prophylaxis of endocarditis.

Authors:  D Stamboulian; E Carbone
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

6.  Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.

Authors:  M Fernandez-Guerrero; M Rouse; N Henry; W Wilson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

7.  Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model.

Authors:  D P Greenberg; A S Bayer; A L Cheung; J I Ward
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

8.  Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.

Authors:  M Herrmann; S J Suchard; L A Boxer; F A Waldvogel; P D Lew
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?

Authors:  C Pigrau; D Rodríguez; A M Planes; B Almirante; N Larrosa; E Ribera; J Gavaldà; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

10.  Infective endocarditis at a hospital in Saudi Arabia: epidemiology, bacterial pathogens and outcome.

Authors:  Jaffar A Al-Tawfiq; Ismail Sufi
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.